| pubmed-article:16338496 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16338496 | lifeskim:mentions | umls-concept:C0007634 | lld:lifeskim |
| pubmed-article:16338496 | lifeskim:mentions | umls-concept:C0026764 | lld:lifeskim |
| pubmed-article:16338496 | lifeskim:mentions | umls-concept:C1707312 | lld:lifeskim |
| pubmed-article:16338496 | lifeskim:mentions | umls-concept:C0024348 | lld:lifeskim |
| pubmed-article:16338496 | lifeskim:mentions | umls-concept:C0003442 | lld:lifeskim |
| pubmed-article:16338496 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
| pubmed-article:16338496 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:16338496 | pubmed:dateCreated | 2005-12-12 | lld:pubmed |
| pubmed-article:16338496 | pubmed:abstractText | Allogeneic stem cell transplantation is a potentially curative therapy for patients with multiple myeloma. Polyclonal antithymocyte globulins (ATG) or monoclonal anti-CD52 (Alemtuzumab) are included in conditioning regimens to enhance engraftment and reduce risk of severe graft-vs-host disease. Because both agents have been reported to induce depletion of B cells, we sought to investigate their cytotoxic activity on myeloma cells. | lld:pubmed |
| pubmed-article:16338496 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16338496 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16338496 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16338496 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16338496 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16338496 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16338496 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16338496 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16338496 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16338496 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16338496 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16338496 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:16338496 | pubmed:issn | 0301-472X | lld:pubmed |
| pubmed-article:16338496 | pubmed:author | pubmed-author:KrögerNicolau... | lld:pubmed |
| pubmed-article:16338496 | pubmed:author | pubmed-author:ZanderAxel... | lld:pubmed |
| pubmed-article:16338496 | pubmed:author | pubmed-author:FehseBorisB | lld:pubmed |
| pubmed-article:16338496 | pubmed:author | pubmed-author:AyukFrancis... | lld:pubmed |
| pubmed-article:16338496 | pubmed:author | pubmed-author:FangLubinL | lld:pubmed |
| pubmed-article:16338496 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16338496 | pubmed:volume | 33 | lld:pubmed |
| pubmed-article:16338496 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16338496 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16338496 | pubmed:pagination | 1531-6 | lld:pubmed |
| pubmed-article:16338496 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:16338496 | pubmed:meshHeading | pubmed-meshheading:16338496... | lld:pubmed |
| pubmed-article:16338496 | pubmed:meshHeading | pubmed-meshheading:16338496... | lld:pubmed |
| pubmed-article:16338496 | pubmed:meshHeading | pubmed-meshheading:16338496... | lld:pubmed |
| pubmed-article:16338496 | pubmed:meshHeading | pubmed-meshheading:16338496... | lld:pubmed |
| pubmed-article:16338496 | pubmed:meshHeading | pubmed-meshheading:16338496... | lld:pubmed |
| pubmed-article:16338496 | pubmed:meshHeading | pubmed-meshheading:16338496... | lld:pubmed |
| pubmed-article:16338496 | pubmed:meshHeading | pubmed-meshheading:16338496... | lld:pubmed |
| pubmed-article:16338496 | pubmed:meshHeading | pubmed-meshheading:16338496... | lld:pubmed |
| pubmed-article:16338496 | pubmed:meshHeading | pubmed-meshheading:16338496... | lld:pubmed |
| pubmed-article:16338496 | pubmed:meshHeading | pubmed-meshheading:16338496... | lld:pubmed |
| pubmed-article:16338496 | pubmed:meshHeading | pubmed-meshheading:16338496... | lld:pubmed |
| pubmed-article:16338496 | pubmed:meshHeading | pubmed-meshheading:16338496... | lld:pubmed |
| pubmed-article:16338496 | pubmed:meshHeading | pubmed-meshheading:16338496... | lld:pubmed |
| pubmed-article:16338496 | pubmed:meshHeading | pubmed-meshheading:16338496... | lld:pubmed |
| pubmed-article:16338496 | pubmed:meshHeading | pubmed-meshheading:16338496... | lld:pubmed |
| pubmed-article:16338496 | pubmed:meshHeading | pubmed-meshheading:16338496... | lld:pubmed |
| pubmed-article:16338496 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:16338496 | pubmed:articleTitle | Antithymocyte globulin induces complement-dependent cell lysis and caspase-dependent apoptosis in myeloma cells. | lld:pubmed |
| pubmed-article:16338496 | pubmed:affiliation | Department of Bone Marrow Transplantation, University Medical Center Hamburg-Eppendorf, Germany. ayuketan@uke.uni-hamburg.de | lld:pubmed |
| pubmed-article:16338496 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16338496 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
